Welcome to Law.com’s Class Actions: Critical Mass, a weekly briefing for class action and mass torts attorneys.
This week: Plaintiffs’ lawyers predict that injuries tied to a Bard medical device could generate thousands of lawsuits. The first Philadelphia trial over Monsanto’s Roundup begins Oct. 5. Find out who will lead lawsuits over the intravenous drug Tepezza.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
